The International Association for the Study of Lung Cancer (IASLC) is a global multidisciplinary organization dedicated to eradicating all forms of lung cancer. Comprised of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists, the IASLC's members are committed to raising the bar for patient care through educational events, research projects, and publications that advance the science of lung cancer. With a focus on collaboration and innovation, the IASLC aims to improve outcomes and quality of life for patients with lung cancer. The IASLC's vision is reflected in its strategic plan for the next five years, which outlines its mission and objectives in the ever-evolving landscape of lung cancer research and patient care. Additionally, the organization has issued a position statement on the documentation of tobacco use in cancer clinical trials, recognizing the negative impact of tobacco on clinical outcomes for cancer patients. Through its initiatives and partnerships, the IASLC is dedicated to addressing global challenges in conquering thoracic cancers and promoting advancements in oncogene-driven lung cancer research.
Generated from the website